herbal concoction of fenugreek and saw palmetto. crowns and one had some regrowth. John Mason, president of the Institute of Trichologists, is less impressed. 'It is unrealistic to expect baldness ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. As sex tech gets more and more advanced, we get closer to ...

Original Medicare does not cover routine dental care or oral surgery for the general health of the teeth. However, Medicare may approve coverage for oral surgery in special cases. Although ...

A CIRCULAR from the Department of Education in KwaZulu-Natal shows that the department has directed the implementing of teaching and learning in mother tongue languages for some grades.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...